Home › Funds › INFINITUM ASSET MANAGEMENT, LLC › AVBP

INFINITUM ASSET MANAGEMENT, LLC position in AVBP

ARRIVENT BIOPHARMA INC COM · Health Care

INFINITUM ASSET MANAGEMENT, LLC reported holding 4,438,384 shares of AVBP (ARRIVENT BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$154.2M, representing 15.68% of its reported portfolio and ranking #2 among its reported holdings. INFINITUM ASSET MANAGEMENT, LLC has disclosed AVBP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)4.44M sh
Reported value held$154.19M
Portfolio Weight15.68%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How INFINITUM ASSET MANAGEMENT, LLC's AVBP position evolved

INFINITUM ASSET MANAGEMENT, LLC first disclosed a stake in AVBP in Q4 2024 at 1,643,923 shares (US$43.8M). The position peaked in Q2 2026 at 4,438,384 shares, worth US$154.2M. Across 7 filings, INFINITUM ASSET MANAGEMENT, LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,438,384 shares valued at US$154.2M — an increase of 289,461 shares quarter over quarter.. Notable position changes include a 26% increase in Q1 2025 (shares rose 18% over the following quarter), a 65% increase in Q2 2025 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 1.64M $43.79M New
Q1 2025 2.07M $38.20M Add
Q2 2025 3.42M $74.43M Add
Q3 2025 3.87M $71.38M Add
Q4 2025 4.12M $82.97M Add
Q1 2026 4.15M $95.72M Add
Q2 2026 4.44M $154.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVBP and 13F data

AVBP (ARRIVENT BIOPHARMA INC COM) is a Health Care company. 60 other funds we track also report a position in AVBP — the largest reported positions include MONTANOVA CAPITAL, LLC (US$156.9M), Hillhouse Capital (HHLR Advisors) (US$136.5M), ORBIMED ADVISORS LLC (US$105.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVBP

All AVBP fund holders →

FAQ

How long has INFINITUM ASSET MANAGEMENT, LLC held AVBP?

INFINITUM ASSET MANAGEMENT, LLC has disclosed AVBP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is INFINITUM ASSET MANAGEMENT, LLC's current position in AVBP?

As of Q2 2026, INFINITUM ASSET MANAGEMENT, LLC holds 4.44M shares of AVBP (ARRIVENT BIOPHARMA INC COM), valued at $154.19M, representing 15.68% of its reported portfolio and ranking #2.

Has INFINITUM ASSET MANAGEMENT, LLC been buying or selling AVBP?

In the latest 13F filing (Q2 2026), INFINITUM ASSET MANAGEMENT, LLC increased its position in AVBP. The position peaked in Q2 2026 at 4.44M shares.

Which other funds hold AVBP?

Other major institutional holders of AVBP include MONTANOVA CAPITAL, LLC, Hillhouse Capital (HHLR Advisors), ORBIMED ADVISORS LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.